1. Home
  2. UVV vs ALVO Comparison

UVV vs ALVO Comparison

Compare UVV & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$54.38

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.40

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
ALVO
Founded
1886
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UVV
ALVO
Price
$54.38
$3.40
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
131.4K
386.6K
Earning Date
05-28-2026
05-06-2026
Dividend Yield
6.25%
N/A
EPS Growth
N/A
N/A
EPS
3.02
N/A
Revenue
$2,922,924,000.00
N/A
Revenue This Year
$0.67
$13.28
Revenue Next Year
$0.10
$18.63
P/E Ratio
$18.06
$18.20
Revenue Growth
7.40
N/A
52 Week Low
$49.96
$3.03
52 Week High
$67.33
$11.85

Technical Indicators

Market Signals
Indicator
UVV
ALVO
Relative Strength Index (RSI) 56.20 47.85
Support Level $53.85 $3.10
Resistance Level $56.52 $3.83
Average True Range (ATR) 0.83 0.19
MACD 0.04 0.00
Stochastic Oscillator 58.81 37.17

Price Performance

Historical Comparison
UVV
ALVO

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: